Name | Number of supported studies | Average coverage | |
---|---|---|---|
goblet cell | 3 studies | 31% ± 15% |
Insufficient scRNA-seq data for expression of FFAR4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 82% | 63.31 | 270 / 328 | 71% | 3.66 | 126 / 178 |
lung | 88% | 234.07 | 507 / 578 | 43% | 1.38 | 495 / 1155 |
intestine | 50% | 387.66 | 482 / 966 | 79% | 12.81 | 416 / 527 |
breast | 72% | 209.75 | 330 / 459 | 54% | 1.06 | 606 / 1118 |
brain | 53% | 81.63 | 1411 / 2642 | 62% | 1.43 | 435 / 705 |
stomach | 31% | 20.18 | 110 / 359 | 64% | 5.08 | 183 / 286 |
adipose | 91% | 358.04 | 1099 / 1204 | 0% | 0 | 0 / 0 |
skin | 52% | 35.14 | 946 / 1809 | 10% | 0.16 | 46 / 472 |
kidney | 9% | 6.36 | 8 / 89 | 46% | 1.39 | 411 / 901 |
adrenal gland | 50% | 33.68 | 130 / 258 | 1% | 0.01 | 2 / 230 |
bladder | 10% | 4.10 | 2 / 21 | 35% | 3.36 | 175 / 504 |
thymus | 13% | 7.79 | 87 / 653 | 29% | 0.59 | 178 / 605 |
esophagus | 14% | 7.80 | 200 / 1445 | 28% | 1.65 | 51 / 183 |
ovary | 1% | 0.19 | 1 / 180 | 33% | 0.67 | 140 / 430 |
tonsil | 0% | 0 | 0 / 0 | 31% | 0.62 | 14 / 45 |
liver | 9% | 3.79 | 21 / 226 | 13% | 0.32 | 52 / 406 |
uterus | 1% | 0.70 | 2 / 170 | 20% | 0.49 | 92 / 459 |
blood vessel | 15% | 16.22 | 197 / 1335 | 0% | 0 | 0 / 0 |
prostate | 7% | 3.01 | 16 / 245 | 8% | 0.43 | 40 / 502 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.09 | 2 / 29 |
heart | 7% | 4.29 | 58 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 6% | 3.15 | 59 / 929 | 0% | 0 | 0 / 0 |
spleen | 6% | 2.58 | 15 / 241 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.58 | 10 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050873 | Biological process | brown fat cell differentiation |
GO_0006954 | Biological process | inflammatory response |
GO_0007200 | Biological process | phospholipase C-activating G protein-coupled receptor signaling pathway |
GO_0070094 | Biological process | positive regulation of glucagon secretion |
GO_0090275 | Biological process | negative regulation of somatostatin secretion |
GO_0032870 | Biological process | cellular response to hormone stimulus |
GO_0045669 | Biological process | positive regulation of osteoblast differentiation |
GO_0032691 | Biological process | negative regulation of interleukin-1 beta production |
GO_0036321 | Biological process | ghrelin secretion |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0090336 | Biological process | positive regulation of brown fat cell differentiation |
GO_0046879 | Biological process | hormone secretion |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
GO_0001818 | Biological process | negative regulation of cytokine production |
GO_0050912 | Biological process | detection of chemical stimulus involved in sensory perception of taste |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0050872 | Biological process | white fat cell differentiation |
GO_0010827 | Biological process | regulation of glucose transmembrane transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0030139 | Cellular component | endocytic vesicle |
GO_0060170 | Cellular component | ciliary membrane |
GO_0005929 | Cellular component | cilium |
GO_0010008 | Cellular component | endosome membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0004930 | Molecular function | G protein-coupled receptor activity |
GO_0008527 | Molecular function | taste receptor activity |
GO_0042277 | Molecular function | peptide binding |
GO_0005504 | Molecular function | fatty acid binding |
Gene name | FFAR4 |
Protein name | Free fatty acid receptor 4 Free fatty acid receptor 4 (G-protein coupled receptor 120) (G-protein coupled receptor 129) (G-protein coupled receptor GT01) (G-protein coupled receptor PGR4) (Omega-3 fatty acid receptor 1) |
Synonyms | PGR4 O3FAR1 GPR120 GPR129 |
Description | FUNCTION: [Isoform 2]: G-protein-coupled receptor for long-chain fatty acids (LCFAs) with a major role in adipogenesis, energy metabolism and inflammation. Signals via G-protein and beta-arrestin pathways . LCFAs sensing initiates activation of phosphoinositidase C-linked G proteins GNAQ and GNA11 (G(q)/G(11)), inducing a variety of cellular responses via second messenger pathways such as intracellular calcium mobilization, modulation of cyclic adenosine monophosphate (cAMP) production, and mitogen-activated protein kinases (MAPKs) . After LCFAs binding, associates with beta-arrestin ARRB2 that acts as an adapter protein coupling the receptor to specific downstream signaling pathways, as well as mediating receptor endocytosis . In response to dietary fats, plays an important role in the regulation of adipocyte proliferation and differentiation (By similarity). Acts as a receptor for omega-3 polyunsaturated fatty acids (PUFAs) at primary cilium of perivascular preadipocytes, initiating an adipogenic program via cAMP and CTCF-dependent chromatin remodeling that ultimately results in transcriptional activation of adipogenic genes and cell cycle entry (By similarity). Induces differentiation of brown adipocytes probably via autocrine and endocrine functions of FGF21 hormone (By similarity). Activates brown adipocytes by initiating intracellular calcium signaling that leads to mitochondrial depolarization and fission, and overall increased mitochondrial respiration (By similarity). Consequently stimulates fatty acid uptake and oxidation in mitochondria together with UCP1-mediated thermogenic respiration, eventually reducing fat mass (By similarity). Regulates bi-potential differentiation of bone marrow mesenchymal stem cells toward osteoblasts or adipocytes likely by up-regulating distinct integrins (By similarity). In response to dietary fats regulates hormone secretion and appetite (By similarity). Stimulates GIP and GLP1 secretion from enteroendocrine cells as well as GCG secretion in pancreatic alpha cells, thereby playing a role in the regulation of blood glucose levels (By similarity). Negatively regulates glucose-induced SST secretion in pancreatic delta cells (By similarity). Mediates LCFAs inhibition of GHRL secretion, an appetite-controlling hormone (By similarity). In taste buds, contributes to sensing of dietary fatty acids by the gustatory system (By similarity). During the inflammatory response, promotes anti-inflammatory M2 macrophage differentiation in adipose tissue (By similarity). Mediates the anti-inflammatory effects of omega-3 PUFAs via inhibition of NLRP3 inflammasome activation . In this pathway, interacts with adapter protein ARRB2 and inhibits the priming step triggered by Toll-like receptors (TLRs) at the level of TAK1 and TAB1 (By similarity). Further inhibits the activation step when ARRB2 directly associates with NLRP3, leading to inhibition of pro-inflammatory cytokine release . Mediates LCFAs anti-apoptotic effects (By similarity). .; FUNCTION: [Isoform 1]: Receptor for LCFAs decoupled from G-protein signaling. May signal through beta-arrestin pathway. After LCFAs binding, associates with beta-arrestin ARRB2 that may act as an adapter protein coupling the receptor to specific downstream signaling pathways, as well as mediating receptor endocytosis. . |
Accessions | ENST00000371481.9 [Q5NUL3-2] Q5NUL3 ENST00000371483.8 [Q5NUL3-1] S4R3L2 ENST00000604414.1 |